I am writing on behalf of MSF to express our disappointment that J&J has not yet placed any patent into the Medicines Patent Pool and that it has announced in a recent letter to the Medicines Patent Pool that it is not ready to engage in formal negotiations.

More >

My name is Dr. Tido von Schoen-Angerer and I am speaking on behalf of Médecins Sans Frontières. Thank you for the opportunity to address this important gathering.

In 2000, I was working in one of MSF’s AIDS projects. Our response to the pandemic was one based on a simple medical decision: faced with the urgency of patients dying, the only acceptable response was to treat. This was an ethical imperative, to treat, regardless of the difficulties.

More >

Speech by STEPHEN LEWIS, UN Special Envoy for HIV/AIDS in Africa

More >

Testimony from MSF Submitted to the Department of Health and Human Services for the Meeting of the International Subcommittee of the Presidential Advisory Council on HIV/AIDS Townhall Meeting on the President's Emergency Plan for AIDS Relief (PEPFAR) Delivered By Rachel M. Cohen, U.S. Director, MSF Campaign for Access to Essential Medicines

More >

cc: Mr JG Zuma; Deputy President; Fax: 012 3233114 Mr A. Erwin; Minister of Trade and Industry; Fax: 012 3227851 Treatment Action Campaign (TAC), info@tac.org.za

Mr TM Mbeki
President of the Republic of South Africa
Pretoria
Fax: 012 3238246

Dear Sir,

More >

A Satatement Delivered by Fred Minandi in Barcelona, Spain, at a satellite meeting co-sponsored by MSF and Health Gap of the XIV International AIDS Conference

More >

A Congressional Briefing delivered in Washington, D.C. by Rachel Cohen, Advocacy Liaison for MSF's Access to Essential Medicines Campaign

More >

An MSF-sponsored panel discussion held at the Graduate Center, CUNY

More >

Delivered by Joelle Tanguy, U.S. Executive Director, MSF, at the Global Health Council HHS Consultations, Washington D.C.

More >